KFDA issues second safety alert on diabetes drug Avandia

The Korea Food and Drug Administration (KFDA) has recently issued another warning on GlaxoSmithKline's blockbuster diabetes drug Avandia after studies found an increase in heart-related deaths among patients taking the drug.

The announcement came as the U.S. Food and Drug Administration (FDA) is reviewing its possible risks. The results are expected to be released in July. If the drug is ban...